相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy
Angela Kwok-Fung Lo et al.
FRONTIERS IN ONCOLOGY (2021)
Dietary patterns and risk of nasopharyngeal carcinoma: a population-based case-control study in southern China
Tingting Huang et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2021)
Epstein-Barr virus infection mediated TP53 and Bcl-2 expression in nasopharyngeal carcinoma pathogenesis
Chittibabu Vatte et al.
MOLECULAR AND CLINICAL ONCOLOGY (2021)
p38β-MAPK11 and its role in female cancers
Periklis Katopodis et al.
JOURNAL OF OVARIAN RESEARCH (2021)
The Role of p38γ in Cancer: From review to outlook
Wentao Xu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Silencing c-Jun inhibits autophagy and abrogates radioresistance in nasopharyngeal carcinoma by activating the PI3K/AKT/mTOR pathway
Yongchu Sun et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study
Ya Cao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
The role of JNK in prostate cancer progression and therapeutic strategies
Ruiyuan Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Cantharidic acid induces apoptosis in human nasopharyngeal carcinoma cells through p38-mediated upregulation of caspase activation
Yi-Ching Chen et al.
ENVIRONMENTAL TOXICOLOGY (2020)
Selective inhibitors for JNK signalling: a potential targeted therapy in cancer
Qinghua Wu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Requirement for epithelial p38α in KRAS-driven lung tumor progression
Jessica Vitos-Faleato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Overcoming Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutated Tumours
Emily L. Paton et al.
JOURNAL OF ONCOLOGY (2020)
Asiatic Acid, Extracted from Centella asiatica and Induces Apoptosis Pathway through the Phosphorylation p38 Mitogen-Activated Protein Kinase in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells
Yen-Tze Liu et al.
BIOMOLECULES (2020)
The p38 Pathway: From Biology to Cancer Therapy
Adrian Martinez-Limon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer
Manel B. Hammouda et al.
CELLS (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Epithelial-Mesenchymal Transition in Cancer: A Historical Overview
Domenico Ribatti et al.
TRANSLATIONAL ONCOLOGY (2020)
Licochalcone A induces apoptotic cell death via JNK/p38 activation in human nasopharyngeal carcinoma cells
Chun-Yi Chuang et al.
ENVIRONMENTAL TOXICOLOGY (2019)
A randomized, double-blind, placebo-controlled phase Ib/II study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine (G) and carboplatin (C) versus GC for women with recurrent platinum-sensitive ovarian cancer.
Ignace Vergote et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Amyloid β precursor protein silencing attenuates epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway
Jin Xu et al.
MOLECULAR MEDICINE REPORTS (2019)
p38γ is essential for cell cycle progression and liver tumorigenesis
Antonia Tomas-Loba et al.
NATURE (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
JNK1/2 represses Lkb1-deficiency-induced lung squamous cell carcinoma progression
Jian Liu et al.
NATURE COMMUNICATIONS (2019)
Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus
Ricardo Rivera-Soto et al.
FRONTIERS IN MICROBIOLOGY (2019)
Management of locally recurrent nasopharyngeal carcinoma
Anne W. M. Leea et al.
CANCER TREATMENT REVIEWS (2019)
LMP1-positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling
Zhibao Zhang et al.
CANCER MEDICINE (2019)
MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancer
Lorenzo Stramucci et al.
CELL DEATH & DISEASE (2019)
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
Cornelia Braicu et al.
CANCERS (2019)
Celastrol, a plant-derived triterpene, induces cisplatin-resistance nasopharyngeal carcinoma cancer cell apoptosis though ERK1/2 and p38 MAPK signaling pathway
Ming-Ju Hsieh et al.
PHYTOMEDICINE (2019)
JNK, p38, ERK, and SGK1 Inhibitors in Cancer
Jonas Cicenas et al.
CANCERS (2018)
Caffeic Acid Phenethyl Ester Induces N-myc Downstream Regulated Gene 1 to Inhibit Cell Proliferation and Invasion of Human Nasopharyngeal Cancer Cells
Kun-Chun Chiang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The role of p38 MAPK pathway in p53 compromised state and telomere mediated DNA damage response
Shomereeta Roy et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2018)
Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization
Yiu To Yeung et al.
EBIOMEDICINE (2018)
Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer
Hoi-Lam Ngan et al.
CANCERS (2018)
Clinicopathologic and prognostic significance of VEGF, JAK2 and STAT3 in patients with nasopharyngeal carcinoma
Jin-Zhang Cheng et al.
CANCER CELL INTERNATIONAL (2018)
Molecular subtyping of nasopharyngeal carcinoma (NPC) and a microRNA-based prognostic model for distant metastasis
Lan Zhao et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment
M. Wada et al.
ONCOGENE (2017)
Epstein-Barr virus infection and nasopharyngeal carcinoma
Sai Wah Tsao et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
Role of JNK signaling in oral cancer: A mini review
Ioannis Gkouveris et al.
TUMOR BIOLOGY (2017)
A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinib
Nancy D. Ebelt et al.
ONCOTARGET (2017)
Prostaglandin E2-mediated adenosinergic effects on CD14+ cells: Self-amplifying immunosuppression in cancer
Saly Al-Taei et al.
ONCOIMMUNOLOGY (2017)
The Prognostic Role of NEDD9 and P38 Protein Expression Levels in Urinary Bladder Transitional Cell Carcinoma
Ola A. Harb et al.
JOURNAL OF ONCOLOGY (2017)
Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line
Sukru Aydin Duzgun et al.
CYTOTECHNOLOGY (2017)
A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer
Amita Patnaik et al.
CLINICAL CANCER RESEARCH (2016)
Monitoring Ras Interactions with the Nucleotide Exchange Factor Son of Sevenless (Sos) Using Site-specific NMR Reporter Signals and Intrinsic Fluorescence
Uybach Vo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel
Manabu Seino et al.
ONCOLOGY REPORTS (2016)
The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer
Xin Jin et al.
CANCER BIOLOGY & THERAPY (2016)
Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia
Lohith Bachegowda et al.
CANCER RESEARCH (2016)
Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development
Juan Wang et al.
TARGETED ONCOLOGY (2016)
Tolfenamic Acid Inhibits the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma: Involvement of p38-Mediated Down-Regulation of Slug
Tatsanachat Jittreetat et al.
YONSEI MEDICAL JOURNAL (2016)
p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells
A. J. Browne et al.
CELL DEATH & DISEASE (2016)
JNK1/2 expression and modulation of STAT3 signaling in oral cancer
Ioannis Gkouveris et al.
ONCOLOGY LETTERS (2016)
The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo
Masashi Okada et al.
ONCOTARGET (2016)
JNK2 downregulation promotes tumorigenesis and chemoresistance by decreasing p53 stability in bladder cancer
Chun-Wu Pan et al.
ONCOTARGET (2016)
Polyphyllin G induce apoptosis and autophagy in human nasopharyngeal cancer cells by modulation of AKT and mitogen-activated protein kinase pathways in vitro and in vivo
Jui-Chieh Chen et al.
ONCOTARGET (2016)
c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease
Ramon Yarza et al.
FRONTIERS IN PHARMACOLOGY (2016)
Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents
Irina A. Vasilevskaya et al.
CLINICAL CANCER RESEARCH (2015)
Nasopharyngeal Cancer: Molecular Landscape
Jeff P. Bruce et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The nuclear translocation of ERK1/2 as an anticancer target
Alexander Plotnikov et al.
NATURE COMMUNICATIONS (2015)
EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma
Lifang Yang et al.
ONCOTARGET (2015)
c-Jun N-terminal kinase inhibitor SP600125 enhances barrier function and elongation of human pancreatic cancer cell line HPAC in a Ca-switch model
Takumi Konno et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2015)
Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin
Jantine PosthumadeBoer et al.
Oncotarget (2015)
An exploratory, randomized, parallel-group, open-label, relative bioavailability study with an additional two-period crossover food-effect study exploring the pharmacokinetics of two novel formulations of pexmetinib (ARRY-614)
Lance A. Wollenberg et al.
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS (2015)
Multifaceted role of matrix metalloproteinases (MMPs)
Divya Singh et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2015)
JNK signalling in cancer: in need of new, smarter therapeutic targets
Concetta Bubici et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
The MAPK Pathway Across Different Malignancies: A New Perspective
Mauricio Burotto et al.
CANCER (2014)
miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma
Juan Lu et al.
CARCINOGENESIS (2014)
14-Thienyl Methylene Matrine (YYJ18), the Derivative from Matrine, Induces Apoptosis of Human Nasopharyngeal Carcinoma Cells by Targeting MAPK and PI3K/Akt Pathways in Vitro
Mao Xie et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Recent Progress in the Design, Study, and Development of c-Jun N-Terminal Kinase Inhibitors as Anticancer Agents
Abdellah Messoussi et al.
CHEMISTRY & BIOLOGY (2014)
SP600125 overcomes antimitotic drug-resistance in cancer cells by increasing apoptosis with independence of P-gp inhibition
Ju-Hwa Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients
Zhixiong Lin et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis
Kantima Leelahavanichkul et al.
MOLECULAR ONCOLOGY (2014)
Functional Roles of p38 Mitogen-Activated Protein Kinase in Macrophage-Mediated Inflammatory Responses
Yanyan Yang et al.
MEDIATORS OF INFLAMMATION (2014)
Etiological factors of nasopharyngeal carcinoma
Sai Wah Tsao et al.
ORAL ONCOLOGY (2014)
Hispolon from Phellinus linteus possesses mediate caspases activation and induces human nasopharyngeal carcinomas cells apoptosis through ERK1/2, JNK1/2 and p38 MAPK pathway
Ming-Ju Hsieh et al.
PHYTOMEDICINE (2014)
JNK Contributes to the Tumorigenic Potential of Human Cholangiocarcinoma Cells through the mTOR Pathway Regulated GRP78 Induction
Chunhong Feng et al.
PLOS ONE (2014)
Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer
Xin-Juan Fan et al.
TUMOR BIOLOGY (2014)
Epstein-Barr virus and nasopharyngeal carcinoma
Lawrence S. Young et al.
CHINESE JOURNAL OF CANCER (2014)
TNF-α up-regulates cellular inhibitor of apoptosis protein 2 (c-IAP2) via c-Jun N-terminal kinase (JNK) pathway in nasopharyngeal carcinoma
Qibin Song et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
JNK inhibitor SP600125 enhances TGF-β-induced apoptosis of RBE human cholangiocarcinoma cells in a Smad-dependent manner
Youzhi Lin et al.
MOLECULAR MEDICINE REPORTS (2013)
BIRB796, the Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells
Dan He et al.
PLOS ONE (2013)
CCAAT/Enhancer Binding Protein δ in Macrophages Contributes to Immunosuppression and Inhibits Phagocytosis in Nasopharyngeal Carcinoma
Yu-Wei Hsiao et al.
SCIENCE SIGNALING (2013)
Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial
William MacNee et al.
THORAX (2013)
Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma
Yan Zhen et al.
CELL DEATH & DISEASE (2013)
Discovery of Potent and Selective Covalent Inhibitors of JNK
Tinghu Zhang et al.
CHEMISTRY & BIOLOGY (2012)
Selective killing of p53-deficient cancer cells by SP600125
Mohamed Jemaa et al.
EMBO MOLECULAR MEDICINE (2012)
Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma
Vipin Yadav et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A Novel Function of p38-Regulated/Activated Kinase in Endothelial Cell Migration and Tumor Angiogenesis
Naoto Yoshizuka et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Increased JNK1 Signaling Pathway Is Responsible for ABCG2-Mediated Multidrug Resistance in Human Colon Cancer
Ming Ming Zhu et al.
PLOS ONE (2012)
Clinical features of 337 patients with recurrent nasopharyngeal carcinoma
Jia-Xin Li et al.
Chinese Journal of Cancer (2012)
The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation
Alexander Plotnikov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma
Qiang Zuo et al.
BIOMEDICINE & PHARMACOTHERAPY (2011)
Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma
Salome Paillas et al.
CANCER RESEARCH (2011)
Cellular Iron Depletion Stimulates the JNK and p38 MAPK Signaling Transduction Pathways, Dissociation of ASK1-Thioredoxin, and Activation of ASK1
Yu Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
BCL2L12 Is a Novel Biomarker for the Prediction of Short-Term Relapse in Nasopharyngeal Carcinoma
Ali Fendri et al.
MOLECULAR MEDICINE (2011)
Mechanisms and functions of p38 MAPK signalling
Ana Cuadrado et al.
BIOCHEMICAL JOURNAL (2010)
Phosphorylated c-Jun NH2-terminal kinase is overexpressed in human papillary thyroid carcinomas and associates with lymph node metastasis
Xiao Wang et al.
CANCER LETTERS (2010)
p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 Activity
Binod Kumar et al.
CANCER RESEARCH (2010)
Epstein-Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-κB and p38 MAPK pathways
Chia-Chun Chen et al.
CELLULAR SIGNALLING (2010)
Expression of bcl-2 correlates with poor prognosis and modulates migration of nasopharyngeal carcinoma cells
Mu-Kuan Chen et al.
CLINICA CHIMICA ACTA (2010)
The JNK inhibitor SP600125 enhances dihydroartemisinin-induced apoptosis by accelerating Bax translocation into mitochondria in human lung adenocarcinoma cells
Ying-Ying Lu et al.
FEBS LETTERS (2010)
A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease
Iris Dotan et al.
GUT (2010)
The p38 Signaling Pathway Upregulates Expression of the Epstein-Barr Virus LMP1 Oncogene
Pegah Johansson et al.
JOURNAL OF VIROLOGY (2010)
Down-Regulation of MMP-2 Through the p38 MAPK-NF-κB-Dependent Pathway by Aloe-Emodin Leads to Inhibition of Nasopharyngeal Carcinoma Cell Invasion
Meng-Liang Lin et al.
MOLECULAR CARCINOGENESIS (2010)
SP600125, an inhibitor of Jnk pathway, reduces viability of relatively resistant cancer cells to doxorubicin
Ju-Hwa Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model
Yong-Jing Gao et al.
EXPERIMENTAL NEUROLOGY (2009)
JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma
Qingshan Chang et al.
MOLECULAR CANCER (2009)
SPECIFIC ACTIVITIES OF INDIVIDUAL c-Jun N-TERMINAL KINASES IN THE BRAIN
W. Haeusgen et al.
NEUROSCIENCE (2009)
Signal integration by JNK and p38 MAPK pathways in cancer development
Erwin F. Wagner et al.
NATURE REVIEWS CANCER (2009)
Transcriptional repression of tissue inhibitor of metalloproteinase-3 by Epstein-Barr virus latent membrane protein 1 enhances invasiveness of nasopharyngeal carcinoma cells
Shu-Hui Chang et al.
ORAL ONCOLOGY (2008)
Calcineurin-mediated dephosphorylation of c-Jun Ser-243 is required for c-Jun protein stability and cell transformation
C-C Huang et al.
ONCOGENE (2008)
p38α and p38δ mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells
M. R. Junttila et al.
ONCOGENE (2007)
Role of mitogen-activated protein kinase kinase 4 in cancer
A. J. Whitmarsh et al.
ONCOGENE (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
Endothelial cell migration during angiogenesis
Laurent Lamalice et al.
CIRCULATION RESEARCH (2007)
BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth
Hiroshi Yasui et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases
Marie A. Bogoyevitch et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2006)
High-level expression, activation, and subcellular localization of p38-MAP kinase in thyroid neoplasms
M. Pomérance et al.
JOURNAL OF PATHOLOGY (2006)
Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses
Nick Giafis et al.
CANCER RESEARCH (2006)
Decreased expression of phosphorylated JNK in breast infiltrating ductal carcinoma is associated with a better overall survival
YT Yeh et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia
Asifa S. Haider et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Serpin squamous cell carcinoma antigen inhibits UV-induced apoptosis via suppression of c-JUN NH2-terminal kinase
C Katagiri et al.
JOURNAL OF CELL BIOLOGY (2006)
Role of JNK activation in apoptosis: A double-edged sword
J Liu et al.
CELL RESEARCH (2005)
Regulation of anoikis by Cdc42 and Rac1
TL Cheng et al.
EXPERIMENTAL CELL RESEARCH (2004)
Breast cancer cells with inhibition of p38 alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice
C Suarez-Cuervo et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
p38 mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression
JQ Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells
T Hideshima et al.
ONCOGENE (2004)
Clinicopathologic significance of plasma matrix metalloproteinase-2 and-9 levels in patients with undifferentiated nasopharyngeal carcinoma
TS Wong et al.
EJSO (2004)
Selective p38 activation in human non-small cell lung cancer
AK Greenberg et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Regulation of proliferation/apoptosis equilibrium by mitogen-activated protein kinases in normal, hyperplastic, and carcinomatous human prostate
M Royuela et al.
HUMAN PATHOLOGY (2002)
Integrin β1 signaling is necessary for transforming growth factor-β activation of p38MAPK and epithelial plasticity
NA Bhowmick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation
JM Kyriakis et al.
PHYSIOLOGICAL REVIEWS (2001)
分享论文
